跳至主要内容
临床试验/ITMCTR2100004976
ITMCTR2100004976招募中1 期

Effect of Sancao Lichang Decoction in the treatment of diarrhea irritable bowel syndrome based on TLR4/MyD88/NF-?B signaling pathway

Xuzhou Central Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. It complies with the diagnostic criteria of Western medicine and the diagnosis criteria of TCM syndrome;
  • 2, Age between 18 and 60, gender is not limited;
  • 3. Have normal communication skills and sign informed consent.

排除标准

  • Diarrhea caused by other organic diseases; The syndrome of traditional Chinese medicine is spleen-kidney Yang deficiency and cold drink stops; Patients with severe cardiovascular and cerebrovascular diseases, respiratory diseases and other diseases and unstable conditions; Organic lesions of the digestive tract, or systemic diseases affecting digestive tract motility; Pregnant and lactating women; Other uncontrolled conditions affect the treatment of the trial.

研究者

发起方
Xuzhou Central Hospital

相似试验